Hepatitis B drug developers chart slow progress forward, just like hep C before it. Read more here.


Liver Cancer Webinar Series

Understanding Disparities in Hep B & Liver Cancer Screening Among High Risk Communities in the US

Panelists: Dr. Patricia Jones, Hepatologist and Researcher, University of Miami

Dr. Moon Chen, Professor and Associate Director of Community Outreach and Engagement, UC Davis Comprehensive Cancer Center

Kenson Alik, Director, Micronesian Education for Liver Wellness Program, Honolulu, HI

Janet Afoakwah, MPH, Executive Director, United States Coalition on African Immigrant Health

View Webinar


gish robertTreatment Options for Liver Cancer

Presented by:  Robert G. Gish, MD, Professor and Consultant, Stanford University, and Medical Director, Hepatitis B Foundation

On behalf of the Hepatitis B Foundation’s Liver Cancer Connect program, world-renowned liver disease specialist Dr. Robert Gish talks about treatment options for liver cancer. How does the stage of the cancer affect treatment? Why are screening and surveillance so important? What are the available treatments and what are the therapies in development? Find out by listening to the webinar!

View webinar

Download the Question & Answer Session


Clinical Trials in Liver Cancer

Presented by: Jill McNairCISCRP, and Kate Levy, BS, Johns Hopkins Gastroenterology & Hepatology

View webinar presentation

Download the Question & Answer Session


Support Services for Families Facing Liver Cancer

Presented by:  Karla Pillote, MSN, CANP, Johns Hopkins Gastroenterology & Hepatology and

Andrea Wilson, MPW, Blue Faery: The Adrienne Wilson Liver Cancer Association 

View webinar presentation

Download the Question & Answer Session